UBS Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-594,919
| Closed | -$40.3M | – | 7475 |
|
|
2019
Q3 | $40.3M | Buy |
594,919
+565,509
| +1,923% | +$38.4M | 0.02% | 642 |
|
|
2019
Q2 | $1.71M | Sell |
29,410
-22,075
| -43% | -$1.28M | ﹤0.01% | 2628 |
|
|
2019
Q1 | $3.61M | Sell |
51,485
-38,233
| -43% | -$2.68M | ﹤0.01% | 1996 |
|
|
2018
Q4 | $5.78M | Buy |
89,718
+62,572
| +231% | +$4.03M | ﹤0.01% | 1595 |
|
|
2018
Q3 | $1.91M | Sell |
27,146
-1,468
| -5% | -$103K | ﹤0.01% | 2644 |
|
|
2018
Q2 | $1.44M | Sell |
28,614
-16,595
| -37% | -$836K | ﹤0.01% | 2789 |
|
|
2018
Q1 | $1.42M | Sell |
45,209
-16,343
| -27% | -$512K | ﹤0.01% | 2776 |
|
|
2017
Q4 | $2.11M | Buy |
61,552
+1,862
| +3% | +$63.7K | ﹤0.01% | 2491 |
|
|
2017
Q3 | $1.92M | Buy |
59,690
+33,391
| +127% | +$1.07M | ﹤0.01% | 2525 |
|
|
2017
Q2 | $856K | Buy |
26,299
+7,290
| +38% | +$237K | ﹤0.01% | 3028 |
|
|
2017
Q1 | $599K | Sell |
19,009
-2,407
| -11% | -$75.8K | ﹤0.01% | 3171 |
|
|
2016
Q4 | $629K | Buy |
21,416
+11,608
| +118% | +$341K | ﹤0.01% | 3148 |
|
|
2016
Q3 | $283K | Sell |
9,808
-1,480
| -13% | -$42.7K | ﹤0.01% | 3496 |
|
|
2016
Q2 | $293K | Sell |
11,288
-5,462
| -33% | -$142K | ﹤0.01% | 3510 |
|
|
2016
Q1 | $415K | Sell |
16,750
-14,250
| -46% | -$353K | ﹤0.01% | 3251 |
|
|
2015
Q4 | $1.09M | Buy |
31,000
+22,271
| +255% | +$784K | ﹤0.01% | 2634 |
|
|
2015
Q3 | $185K | Buy |
8,729
+2,753
| +46% | +$58.3K | ﹤0.01% | 3764 |
|
|
2015
Q2 | $166K | Buy |
5,976
+2,864
| +92% | +$79.6K | ﹤0.01% | 3995 |
|
|
2015
Q1 | $95K | Buy |
3,112
+962
| +45% | +$29.4K | ﹤0.01% | 4217 |
|
|
2014
Q4 | $69K | Buy |
+2,150
| New | +$69K | ﹤0.01% | 4466 |
|